mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.6 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |